Skip to content

Comparison of the pregnancy outcomes in patients with the polycystic ovarian syndrome in two endometrial preparation method GnRHagonist plus hormone replacement therapy versus hormone replacement therapy frozen embryo transfer cycle

Comparison of the pregnancy outcomes in patients with the polycystic ovarian syndrome in two endometrial preparation method GnRHagonist plus hormone replacement therapy versus hormone replacement therapy frozen embryo transfer cycle

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20090526001952N15
Enrollment
124
Registered
2021-05-22
Start date
2021-06-10
Completion date
Unknown
Last updated
2021-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility. Female infertility associated with anovulation

Interventions

Intervention 1: Intervention group:In the HRT group, from the second day of the cycle, he receives 2 mg of estradiol daily and this drug is increased to 6 mg per day in three days.Ten days later, they

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: The first or second cycle of embryo transfer Normal uterine cavity PCO diagnosis based on Rotterdam criteria and correction (2018) Age 20 to 40 years

Exclusion criteria

Exclusion criteria: Infertility with severe male factor endometriosis immunological disease FSH higher than 10 BMI greater than or equal to 30 Endometrial thickness on the day of transfer is less than 7 mm History of recurrent miscarriage

Design outcomes

Primary

MeasureTime frame
Endometrial thickness. Timepoint: On the day of transfer. Method of measurement: transvaginal ultrasound.;Chemical pregnancy. Timepoint: 14 days after transfer. Method of measurement: Beta HCG Test.;Clinical pregnancy. Timepoint: 7 weeks of pregnancy. Method of measurement: Transvaginal Ultrasound.;Ongoing pregnancy. Timepoint: 12 weeks of pregnancy. Method of measurement: Ultrasonography.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAshraf Moini

Tehran University of Medical Sciences

hosp_arash@tums.ac.ir+98 21 7788 3283

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026